4.6 Review

Understanding ALS: new therapeutic approaches

Journal

FEBS JOURNAL
Volume 280, Issue 17, Pages 4315-4322

Publisher

WILEY
DOI: 10.1111/febs.12087

Keywords

ALS-associated genes; amyotrophic lateral sclerosis; complexity of ALS pathogenesis; growth factors; mutant SOD1 toxicity; neuromuscular disease; oxidative stress; skeletal muscle; stem cells; therapeutic approaches

Funding

  1. Seventh Framework Programme Myoage [223576]
  2. Fondation Thierry Latran
  3. Fondazione Roma
  4. Ministero dell'Istruzione, dell' Universita e della Ricerca (MIUR)
  5. Association Francaise contre Myopathie (AFM)

Ask authors/readers for more resources

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease associated with motor neuron degeneration, muscle atrophy and paralysis. Although numerous pathological mechanisms have been elucidated, ALS remains an invariably fatal disease in the absence of any effective therapy. The heterogeneity of the disease and the failure to develop satisfactory therapeutic protocols reinforce the view that ALS is a multi-factorial and multi-systemic disease. Thus, a better understanding of the pathogenic mechanisms and study of the potential pathological relationship between the various cellular processes is required to ensure efficacious therapy. The pathogenic mechanisms associated with ALS are reviewed, and the strengths and limitations of some new therapeutic approaches are discussed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available